SPRR2A and metastatic malignant neoplasm in the lymph nodes: SPRR2A is overexpressed in lymph node metastases, along with an association to non-oropharyngeal location of the primary tumour and is an independent prognostic factor for regional disease recurrence after surgery and radiotherapy.